Asked by: Luke Evans (Conservative - Hinckley and Bosworth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of pharmacies who have not been paid for carrying out Pharmacy First Consultations due to a shortening in the claim window in June 2025.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.
Asked by: Luke Evans (Conservative - Hinckley and Bosworth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate he has made of the NHS's refusal rate in paying pharmacies for carrying out Pharmacy First Services.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.
Asked by: Shaun Davies (Labour - Telford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the gender breakdown is of maternity services staff for each NHS trust.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.
Asked by: Luke Evans (Conservative - Hinckley and Bosworth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate he has made of the (a) number of pharmacy contractors who are due outstanding payments from the NHSBSA for Pharmacy First Services and (b) total value of outstanding payments.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.
Asked by: Luke Evans (Conservative - Hinckley and Bosworth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of shortening the Pharmacy First Service claim window in June 2025 on pharmacies carrying out that service.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.
Asked by: Luke Evans (Conservative - Hinckley and Bosworth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the NHSBSA provide timely payments to pharmacists carrying out Pharmacy First consultations.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.
Asked by: Alex Brewer (Liberal Democrat - North East Hampshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of retail sold magnets on the safety of cerebrospinal fluid shunts programmable externally by magnets.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring that medicines, medical devices, and blood components for transfusions on the market in the United Kingdom are safe, effective, and manufactured to the highest standards of quality. The Medical Devices Regulations 2002 (MDR 2002) establish the statutory framework that medical devices must meet in order to comply with these standards.
All medical devices, including cerebrospinal fluid shunts programmable externally by magnets, must comply with the MDR 2002, which include bearing the UKCA or CE marking on the packaging or labelling of the device. Manufacturers or their UK representatives must monitor use of these devices when used in the UK. The manufacturer holds the legal responsibility for obtaining the necessary certification and registering their medical devices with the MHRA, the UK Competent Authority. Higher risk medical devices are assessed and approved by Approved Bodies in the UK or Notified Bodies in the European Union.
As part of meeting the requirements of the regulations, manufacturers have to provide instructions which would include any special operating instructions, any warnings and/or precautions to take, and precautions to be taken as regards exposure, in reasonably foreseeable environmental conditions, to magnetic fields. In addition, some manufacturers provide further standalone information on this topic, an example of which is available at the following link:
Asked by: Rebecca Paul (Conservative - Reigate)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many detransitioners from the Early Intervention Study run by the Tavistock Gender Identity Development Service (GIDS) in 2011-14 have presented to the NHS for either medical injury or regret; and how many detransitioners, in total, have presented to the NHS for either medical injury or regret since the Cass review was commissioned.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Data and research on detransition has been limited and the number of individuals who may wish to seek help from the National Health Service is not held.
In line with recommendation 25 of the Cass Review, NHS England is developing a clinical pathway for individuals who wish to detransition. Between October and December 2025, NHS England held a 'call for evidence' aimed at healthcare professionals and medical bodies, and the responses will help to shape the development of a care pathway and service specification which NHS England plans to consult on in the summer of 2026.
Asked by: Connor Rand (Labour - Altrincham and Sale West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to regulate non-surgical aesthetic procedures.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
On 7 August 2025, the Government announced its plans to introduce measures to improve the safety of the cosmetics sector. This included prioritising the introduction of legal restrictions which will ensure that the highest risk cosmetic procedures are brought into Care Quality Commission regulation and can only be performed by specified regulated healthcare professionals.
In addition, the Government also committed to legislating to introduce a licensing scheme in England for lower risk procedures through powers granted through the Health and Care Act 2022. Under this scheme, which will be operated by local authorities, practitioners will be required to obtain a licence to perform specified cosmetic procedures, and the premises from which they operate will also need to be licensed. To protect children and young people, the Government is also committed to mandating age restrictions for cosmetic procedures.
The proposals will be taken forward through secondary legislation and therefore will be subject to the parliamentary process before the legal restrictions, or licensing regulations, can be introduced. We are now working with stakeholders to develop detailed plans and intend to consult on proposals for restrictions around the performance of the highest risk procedures in the spring.
Asked by: Nadia Whittome (Labour - Nottingham East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of long working hours and workforce burnout on staff wellbeing, retention and safe staffing levels within the NHS.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
We know from engagement on the 10-Year Health Plan that many National Health Service staff feel disempowered and overwhelmed. Tackling this and providing proper support for staff is a top priority. NHS organisations have a responsibility to create supportive working environments for staff, ensuring they have the conditions they need to thrive, including access to high quality health and wellbeing support.
The Government is committed to publishing a 10 Year Workforce Plan which will have a focus on supporting and retaining our hardworking and dedicated healthcare professionals. This includes the development of a new set of staff standards for modern employment, which will reaffirm our commitment to improving retention and are likely to focus on flexible working, improving staff health and wellbeing and dealing with violence, racism, and sexual harassment in the NHS workplace. Additionally, we will roll out Staff Treatment Hubs that will ensure staff have access to high quality support for occupational health, including support for mental health and back conditions.